Your browser doesn't support javascript.
loading
Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis.
Elmunzer, B Joseph; Singal, Amit G; Sussman, Jeremy B; Deshpande, Amar R; Sussman, Daniel A; Conte, Marisa L; Dwamena, Ben A; Rogers, Mary A M; Schoenfeld, Philip S; Inadomi, John M; Saini, Sameer D; Waljee, Akbar K.
Afiliación
  • Elmunzer BJ; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Singal AG; Department of Internal Medicine, Division of Digestive and Liver Diseases and the Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Sussman JB; Center for Clinical Management Research, Ann Arbor Veterans Affairs Healthcare System, Ann Arbor, Michigan, USA; Department of Internal Medicine, Division of General Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Deshpande AR; Department of Internal Medicine, Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Sussman DA; Department of Internal Medicine, Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Conte ML; University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Dwamena BA; Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Rogers MA; Department of Internal Medicine, Division of General Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Schoenfeld PS; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, Michigan, USA; Center for Clinical Management Research, Ann Arbor Veterans Affairs Healthcare System, Ann Arbor, Michigan, USA.
  • Inadomi JM; Department of Medicine, Division of Gastroenterology, University of Washington School of Medicine, Seattle, Washington, USA.
  • Saini SD; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, Michigan, USA; Center for Clinical Management Research, Ann Arbor Veterans Affairs Healthcare System, Ann Arbor, Michigan, USA.
  • Waljee AK; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, Michigan, USA; Center for Clinical Management Research, Ann Arbor Veterans Affairs Healthcare System, Ann Arbor, Michigan, USA.
Gastrointest Endosc ; 81(3): 700-709.e3, 2015 Mar.
Article en En | MEDLINE | ID: mdl-25708757
ABSTRACT

BACKGROUND:

Comparative effectiveness data pertaining to competing colorectal cancer (CRC) screening tests do not exist but are necessary to guide clinical decision making and policy.

OBJECTIVE:

To perform a comparative synthesis of clinical outcomes studies evaluating the effects of competing tests on CRC-related mortality.

DESIGN:

Traditional and network meta-analyses. Two reviewers identified studies evaluating the effect of guaiac-based fecal occult blood testing (gFOBT), flexible sigmoidoscopy (FS), or colonoscopy on CRC-related mortality.

INTERVENTIONS:

gFOBT, FS, colonoscopy. MAIN OUTCOME MEASUREMENTS Traditional meta-analysis was performed to produce pooled estimates of the effect of each modality on CRC mortality. Bayesian network meta-analysis (NMA) was performed to indirectly compare the effectiveness of screening modalities. Multiple sensitivity analyses were performed.

RESULTS:

Traditional meta-analysis revealed that, compared with no intervention, colonoscopy reduced CRC-related mortality by 57% (relative risk [RR] 0.43; 95% confidence interval [CI], 0.33-0.58), whereas FS reduced CRC-related mortality by 40% (RR 0.60; 95% CI, 0.45-0.78), and gFOBT reduced CRC-related mortality by 18% (RR 0.82; 95% CI, 0.76-0.88). NMA demonstrated nonsignificant trends favoring colonoscopy over FS (RR 0.71; 95% CI, 0.45-1.11) and FS over gFOBT (RR 0.74; 95% CI, 0.51-1.09) for reducing CRC-related deaths. NMA-based simulations, however, revealed that colonoscopy has a 94% probability of being the most effective test for reducing CRC mortality and a 99% probability of being most effective when the analysis is restricted to screening studies.

LIMITATIONS:

Randomized trials and observational studies were combined within the same analysis.

CONCLUSION:

Clinical outcomes studies demonstrate that gFOBT, FS, and colonoscopy are all effective in reducing CRC-related mortality. Network meta-analysis suggests that colonoscopy is the most effective test.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Colonoscopía / Detección Precoz del Cáncer / Sangre Oculta Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Screening_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Gastrointest Endosc Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Colonoscopía / Detección Precoz del Cáncer / Sangre Oculta Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Screening_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Gastrointest Endosc Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos